| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/08/2004 | US20040132157 Novel protein and DNA thereof |
| 07/08/2004 | US20040132156 Modified hepsin molecules having a substitute activation sequence and uses thereof |
| 07/08/2004 | US20040132143 using the hyaluronate or chondroitin or heparin/heparosan synthases from Pasteurella, in order to create a variety of glycosaminoglycan oligosaccharides having a natural or chimeric or hybrid sugar structure with a targeted size |
| 07/08/2004 | US20040132141 Using peripheral blood lymphocytes to generate immunoglobulins for treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 07/08/2004 | US20040132140 comprises using a cell resistant to a lectin which recognizes a sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in the reducing end through alpha -bond in a complex N-glycoside-linked sugar chain |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease |
| 07/08/2004 | US20040132120 Cell regulatory genes, encoded products, and uses related thereto |
| 07/08/2004 | US20040132112 Using transgenic cell coated microbead matrix for screening monoclonal antibodies and monoclonal antibody-producing cells; isolation of immunotherapeutic agents |
| 07/08/2004 | US20040132105 by blotting assays and affinity chromatography of activated platelets or activated endothelial cell (labeled HL-60 cell) extracts |
| 07/08/2004 | US20040132101 Immunoglobulin for use as tool in treatment of cancer; antitumor agents; immunotherapy |
| 07/08/2004 | US20040132097 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors |
| 07/08/2004 | US20040132075 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 07/08/2004 | US20040132069 Method to measure gene expression ratio of key genes |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132052 Comprises nucleotide sequences coding cell signaling glycoprotein for use in screening and identifying antagonist of cancer; tumor diagnosis and treatment; antitumor agents; drug screening |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132030 Identification of neuroblastoma tumor suppressor genes |
| 07/08/2004 | US20040132022 Comprises nucleotide sequences coding growth factor for treatment and prevention of aberrations in cellular growth and differentiation; cancer diagnosis and treatment; antitumor agents |
| 07/08/2004 | US20040132021 Using presence of genetic variation in van buchem-sclerosteosis disease region to identify disorders resulting in either net excess bone formation or insufficient bone formation in humans; allelicvariation and bone disorders |
| 07/08/2004 | US20040132020 Novel enzyme gene and its expression product |
| 07/08/2004 | US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 07/08/2004 | US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 07/08/2004 | US20040132010 Immunogen |
| 07/08/2004 | US20040131640 Escape mutants of newcastle disease virus as marker vaccines |
| 07/08/2004 | US20040131634 Neisseria lactoferrin binding protein |
| 07/08/2004 | US20040131633 Induce immunology response; polypeptide |
| 07/08/2004 | US20040131632 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/08/2004 | US20040131622 Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids |
| 07/08/2004 | US20040131621 Combinations and kits for treating viral infections using antibodies to aminophospholipids |
| 07/08/2004 | US20040131620 Human polyclonal antibody compositions |
| 07/08/2004 | US20040131618 Anticancer agents; diagnosis using alternation of gene expression |
| 07/08/2004 | US20040131617 Anticancer, antitumor agents; brain disorders; skin disorders; polyclonal antibodies |
| 07/08/2004 | US20040131616 Methods of inhibiting proliferative diseases |
| 07/08/2004 | US20040131615 Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same |
| 07/08/2004 | US20040131614 Treatment of pulmonary disorders using TNFalpha inhibitor |
| 07/08/2004 | US20040131613 Nucleic acid sequences; in situ neutralization cytolysis; autoimmune diseases; antiarthritic agents; sepsis |
| 07/08/2004 | US20040131612 Nucleic acid sequence; in situ neutralization |
| 07/08/2004 | US20040131611 Antitumor agents, anticancer agents; synergistic mixture |
| 07/08/2004 | US20040131610 Antitumor, anticancer agents; complexing phosphatide with antibody, duramycin; prevent reproduction of virus |
| 07/08/2004 | US20040131609 Ultra high affinity neutralizing antibodies |
| 07/08/2004 | US20040131608 Antibodies; suppression, therapy, prevention |
| 07/08/2004 | US20040131607 Antiischemic agents; genetic engineered antibody |
| 07/08/2004 | US20040131596 Method and compositions for modifying target receptor function associated with neurological disorders |
| 07/08/2004 | US20040131591 Vector system |
| 07/08/2004 | US20040131585 Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 07/08/2004 | DE10261223A1 Steigerung der Immunantwort durch Substanzen, welche die Funktion von Natürlichen Killerzellen beeinflussen Increasing the immune response by substances which influence the function of natural killer cells |
| 07/08/2004 | DE10259713A1 Verfahren zur Expressionsstabilisierung und Verbesserung der spezifischen Effektorfunktion von Einzelketten-Antigenerkennenden genetischen Konstrukten (scARC) und entsprechend mutierten MDM2-Protein spezifischen scT-Zell Rezeptoren A method for expressing stabilization and improvement of specific effector function of single-chain antigen knower genetic constructs (scARC) and corresponding mutant MDM2 protein specific SCT-cell receptors |
| 07/08/2004 | CA2510859A1 Neuropilin-1 inhibitors |
| 07/08/2004 | CA2510787A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| 07/08/2004 | CA2510715A1 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | CA2508660A1 Antibodies against pd-1 and uses therefor |
| 07/08/2004 | CA2508273A1 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | CA2507898A1 Immunoglobulin variants and uses thereof |
| 07/08/2004 | CA2507637A1 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | CA2507099A1 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis |
| 07/07/2004 | EP1435521A1 Detection and diagnosis of transmissible spongiform encephalopathies |
| 07/07/2004 | EP1435205A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 07/07/2004 | EP1434881A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
| 07/07/2004 | EP1434879A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 07/07/2004 | EP1434874A1 Immunoaffinity isolation of modified peptides from complex mixtures |
| 07/07/2004 | EP1434871A1 Selection of cells expressing heteromeric polypeptides |
| 07/07/2004 | EP1434866A2 Genes associated with mast cell activation |
| 07/07/2004 | EP1434865A2 Variants and exons of the glyt1 transporter |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434856A2 Activation and expansion of cells |
| 07/07/2004 | EP1434802A1 Human tissue factor antibodies |
| 07/07/2004 | EP1434801A2 Treatment for central nervous system disorders |
| 07/07/2004 | EP1434800A2 Immunoglobulin having particular framework scaffold and methods of making and using |
| 07/07/2004 | EP1434799A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434793A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434596A1 Enhancement of immune responses by 4-1bb-binding agents |
| 07/07/2004 | EP1434592A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 07/07/2004 | EP1434483A2 NUCLEIC ACIDS ENCODING LINKED CHROMO/FLUORESCENT DOMAINS AND METHODS FOR USING THE SAME |
| 07/07/2004 | CN1511163A Method for preparing and selecting antibodies |
| 07/07/2004 | CN1511041A Methods of treating antibody-mediated pathologies using agents which inhibit CD 21 |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1510135A Polypeptide-human protein kinase 35 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510134A Polypeptide human protein tyrosine kinase 50 and polynucleotide for encoding it |
| 07/07/2004 | CN1510133A Polypeptide-human protein kinase 38 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510131A Polypeptide-human respiratory chain NADH dehydrogenase 10 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510130A Attenuated cattle viral diarrhoea virus |
| 07/07/2004 | CN1510052A Tumour necrosis factor antibody preparing method and medicinal composition thereof |
| 07/07/2004 | CN1510051A Polypeptide-human cytochrome C oxidase COII protein9 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510050A Polypeptide-human ribosome L39 protein 9 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510049A Polypeptide-human DBH and PAM20, polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510048A Polypeptide-human ribosomal S9 protein 26 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510047A Polypeptide-human guanine mutual change factor 12 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510046A Polypeptide-human mitochondrial carrier 14 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510045A Polypepetide-human Kringle protein 8 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510044A Polypeptide-human beta-transductor 41 and polynucleotide for encoding said polypeptide |
| 07/07/2004 | CN1510043A Polypeptide-human mitochondrial carrier 30 and polynucleotide for coding this polypeptide |
| 07/07/2004 | CN1510042A Polypeptide-Human PAX protein 12 and polynucleotide for coding this polypeptide |
| 07/07/2004 | CN1510041A Polypeptide-human bromo structural protein 9 and polynucleotide for encoding said poly peplide |
| 07/06/2004 | US6760612 Radioactive or magnetic labeled detector molecule which has binding specificity for an epitope of shed tumor antigen administered to patient who is them scanned for localization and concentration of detector |